Group B Streptococcus Early-Onset Disease: New Preventive and Diagnostic Tools to Decrease the Burden of Antibiotic Use

• Published in: Antibiotics (Basel) Vol. 12; no. 3; p. 489
• Main Authors: Nusman, Charlotte M, Snoek, Linde, van Leeuwen, Lisanne M, Dierikx, Thomas H, van der Weijden, Bo M, Achten, Niek B, Bijlsma, Merijn W, Visser, Douwe H, van Houten, Marlies A, Bekker, Vincent, de Meij, Tim G J, van Rossem, Ellen, Felderhof, Mariet, Plötz, Frans B
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.03.2023; MDPI
• Subjects: Age; Antibiotics; Antibodies; Biomarkers; blood culture; Childbirth & labor; Disease prevention; early-onset neonatal sepsis; Group B Streptococcus; guidelines; Immunization; Neonates; Pathogens; Pregnancy; Review; Risk assessment; Sepsis; Serology; Signs and symptoms; Standardization; Streptococcus; Streptococcus infections; Umbilical cord; Vaccines; Virulence; Virulence factors; Womens health; molecular culture techniques; Group B Streptococcus; biomarkers; early-onset neonatal sepsis; guidelines; antibiotics; blood culture
• ISSN: 2079-6382; 2079-6382
• DOI: 10.3390/antibiotics12030489

The difficulty in recognizing early-onset neonatal sepsis (EONS) in a timely manner due to non-specific symptoms and the limitations of diagnostic tests, combined with the risk of serious consequences if EONS is not treated in a timely manner, has resulted in a low threshold for starting empirical antibiotic treatment. New guideline strategies, such as the neonatal sepsis calculator, have been proven to reduce the antibiotic burden related to EONS, but lack sensitivity for detecting EONS. In this review, the potential of novel, targeted preventive and diagnostic methods for EONS is discussed from three different perspectives: maternal, umbilical cord and newborn perspectives. Promising strategies from the maternal perspective include Group B (GBS) prevention, exploring the virulence factors of GBS, maternal immunization and antepartum biomarkers. The diagnostic methods obtained from the umbilical cord are preliminary but promising. Finally, promising fields from the newborn perspective include biomarkers, new microbiological techniques and clinical prediction and monitoring strategies. Consensus on the definition of EONS and the standardization of research on novel diagnostic biomarkers are crucial for future implementation and to reduce current antibiotic overexposure in newborns.